Patient Protection and Affordable Care Act Expands Preferential 340B Drug Pricing To New Entities

Foley Partner Frederick Geilfuss and Associate Maureen Kwiecinski authored an article that appeared in the July 2010 issue of Bloomberg’s Health Law Report titled “Patient Protection and Affordable Care Act Expands Preferential 340B Drug Pricing To New Entities.”